• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昆虫超敏反应免疫疗法的对照试验。

A controlled trial of immunotherapy in insect hypersensitivity.

作者信息

Hunt K J, Valentine M D, Sobotka A K, Benton A W, Amodio F J, Lichtenstein L M

出版信息

N Engl J Med. 1978 Jul 27;299(4):157-61. doi: 10.1056/NEJM197807272990401.

DOI:10.1056/NEJM197807272990401
PMID:78446
Abstract

Insect hypersensitivity is currently treated by immunization using whole-body extracts. We compared this regimen with immunotherapy using insect venoms or placebo in groups of 20 patients matched for history and sensitivity, as judged by venom skin test, histamine release and IgE antibody to venom. After six to 10 weeks of immunization, systemic reactions to stings occurred in seven of 12, seven of 11, and one of 18 patients treated with placebo, whole-body extract, and venom, respectively. Placebo and whole-body extract gave similar results and were significantly less effective than venom immunotherapy (P less than 0.01). The 14 patients with failure of treatment with whole-body extract and placebo were subsequently provided with venom immunotherapy; one reacted to a subsequent sting. We conclude that venom immunotherapy is clinically superior to therapy on whole-body extract or placebo.

摘要

目前,昆虫过敏症是通过使用全身体液提取物进行免疫治疗的。我们将这种治疗方案与使用昆虫毒液或安慰剂的免疫疗法进行了比较,研究对象为20组根据病史和敏感性匹配的患者,敏感性通过毒液皮肤试验、组胺释放以及针对毒液的IgE抗体来判断。免疫治疗6至10周后,接受安慰剂、全身体液提取物和毒液治疗的患者中,分别有12例中的7例、11例中的7例和18例中的1例出现了对叮咬的全身反应。安慰剂和全身体液提取物的效果相似,且明显不如毒液免疫疗法有效(P小于0.01)。接受全身体液提取物和安慰剂治疗无效的14名患者随后接受了毒液免疫疗法;其中1人在后续的叮咬中出现了反应。我们得出结论,毒液免疫疗法在临床上优于全身体液提取物或安慰剂治疗。

相似文献

1
A controlled trial of immunotherapy in insect hypersensitivity.昆虫超敏反应免疫疗法的对照试验。
N Engl J Med. 1978 Jul 27;299(4):157-61. doi: 10.1056/NEJM197807272990401.
2
The value of immunotherapy with venom in children with allergy to insect stings.昆虫叮咬过敏儿童使用毒液免疫疗法的价值。
N Engl J Med. 1990 Dec 6;323(23):1601-3. doi: 10.1056/NEJM199012063232305.
3
Adverse reactions to venom immunotherapy.抗蛇毒免疫疗法的不良反应。
Ann Allergy. 1981 Dec;47(6):435-9.
4
Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.毒液免疫疗法:对3天快速免疫疗法方案的耐受性
Allergol Immunopathol (Madr). 1995 Nov-Dec;23(6):277-84.
5
[Results of hyposensitization with bee and wasp venom].[蜜蜂和黄蜂毒液减敏治疗的结果]
Z Erkr Atmungsorgane. 1986;166(1):119-24.
6
[Therapy control of specific hymenoptera venom allergy].[特定膜翅目昆虫毒液过敏的治疗控制]
Laryngorhinootologie. 2010 Dec;89(12):725-8. doi: 10.1055/s-0030-1267972. Epub 2010 Dec 3.
7
Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.三天速发毒液免疫疗法治疗蜂过敏:安全、廉价且即刻有效。
Int Arch Allergy Immunol. 2011;156(1):90-8. doi: 10.1159/000322258. Epub 2011 Mar 30.
8
[Immunotherapy against hymenoptera venom: report of ten patients].[针对膜翅目毒液的免疫疗法:十例患者报告]
Rev Med Chil. 2007 Dec;135(12):1566-71. Epub 2008 Feb 13.
9
[Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].[蜂毒的快速减敏疗法。耐受性及治疗结果]
Dtsch Med Wochenschr. 1987 Mar 13;112(11):416-24. doi: 10.1055/s-2008-1068068.
10
Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.快速毒液免疫疗法在治疗膜翅目过敏患者中常规使用是安全的。
Ann Allergy. 1994 Nov;73(5):423-8.

引用本文的文献

1
Trends and hotspots on hymenoptera venom immunotherapy: a bibliometric and visualized analysis of research from 2014 to 2024.膜翅目毒液免疫疗法的研究趋势与热点:2014年至2024年研究的文献计量学与可视化分析
Front Immunol. 2025 Apr 30;16:1546704. doi: 10.3389/fimmu.2025.1546704. eCollection 2025.
2
Advances in Allergen Immunotherapy and Safety.变应原免疫疗法的进展与安全性
Vaccines (Basel). 2025 Feb 23;13(3):221. doi: 10.3390/vaccines13030221.
3
Hymenoptera venom allergy in children.儿童蜂类毒液过敏
Ital J Pediatr. 2024 Dec 20;50(1):262. doi: 10.1186/s13052-024-01731-9.
4
Risk Factors Associated with Severe Systemic Allergic Reaction after Wasp Sting in Subjects with a History of European Hornet Sting Allergy.有欧洲大黄蜂蜇伤过敏史的受试者黄蜂蜇伤后严重全身过敏反应的相关危险因素。
Zdr Varst. 2024 Mar 20;63(2):66-72. doi: 10.2478/sjph-2024-0010. eCollection 2024 Jun.
5
Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).膜翅目昆虫毒液过敏的诊断与治疗:德国变态反应与临床免疫学会(DGAKI)与职业与环境皮肤病学会(ABD)、德国变态反应科医生协会(AeDA)、德国皮肤病学会(DDG)、德国耳鼻咽喉头颈外科学会(DGHNOKC)、德国儿科学与青少年医学学会(DGKJ)、儿童变态反应与环境医学学会(GPA)、德国呼吸学会(DGP)以及奥地利变态反应与免疫学会(ÖGAI)联合发布的S2k指南
Allergol Select. 2023 Oct 2;7:154-190. doi: 10.5414/ALX02430E. eCollection 2023.
6
Hymenoptera Venom Immunotherapy in Dogs: Safety and Clinical Efficacy.犬类的膜翅目毒液免疫疗法:安全性与临床疗效
Animals (Basel). 2023 Sep 23;13(19):3002. doi: 10.3390/ani13193002.
7
Venom immunotherapy protocols in the pediatric population: how to choose?儿科人群的毒液免疫疗法方案:如何选择?
Front Pediatr. 2023 Sep 7;11:1192081. doi: 10.3389/fped.2023.1192081. eCollection 2023.
8
Safety and adverse reactions in subcutaneous allergen immunotherapy: a review.皮下变应原免疫治疗的安全性和不良反应:综述。
Acta Biomed. 2023 Aug 3;94(4):e2023172. doi: 10.23750/abm.v94i4.14239.
9
111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases.111年的变应原免疫疗法:这是过敏性疾病中唯一可用的疾病改良疗法漫长且成功的历史。
Allergol Select. 2022 Nov 21;6:248-258. doi: 10.5414/ALX02330E. eCollection 2022.
10
Allergen immunotherapy: past, present and future.变应原免疫治疗:过去、现在和未来。
Nat Rev Immunol. 2023 May;23(5):317-328. doi: 10.1038/s41577-022-00786-1. Epub 2022 Oct 17.